Mednet Logo
HomeRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

How does an incidental finding of low bone density on imaging done for another reason inform your screening approach for osteoporosis?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · Indiana University School of Medicine

In patients with CKD, I would also look for changes on the plan radiographs of secondary hyperparathyroidism. For example, erosion of the distal tufts of the phalanges on hand films, erosion of the clavicle, and arterial calcification. If these findings are present, then it signifies hyperparathyroi...

How do you decide between initiating systemic immunotherapy versus local treatment for uveitis with associated HLA-B27 and spondyloarthropathy?

1 Answers

Mednet Member
Mednet Member
Ophthalmology · University of Arkansas for Medical Sciences, Fayetteville Campus

I find that most, but not all, HLA-B27 iritis can be controlled with topical therapies. To do so requires eliminating other causes of inflammation. Many patients have GI inflammation due to gluten and dairy, despite not having classic celiac disease or lactose intolerance. Reducing their intake, mod...

How do you incorporate hyperbaric oxygen therapy into the care of patients with wounds related to ischemic ulcerations?

3 Answers

Mednet Member
Mednet Member
Rheumatology · Cedars-Sinai Medical Center

Hyperbaric oxygen therapy (HBOT) is intended to improve local tissue hypoxia in non-healing ulcers. Evidence for its use remains limited, primarily consisting of case reports and small case series. Most documented cases involve lower-extremity ulcers, often related to macrovascular disease. For digi...

How often do you perform nailfold capillaroscopy in your clinical practice in patients with CTD?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · North Bristol NHS Trust

In an ideal world, I would perform nailfold cap on all patients (to gain prognostic information on the extent of disease progression), but this is not feasible, and nailfold cap is not always necessary from a diagnostic perspective if the diagnosis is already clear. It is most useful when the diagno...

How do you approach the diagnostic evaluation of osteoporosis in CKD when renal dysfunction limits use of certain tests or biomarkers?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · Indiana University School of Medicine

DEXA is still appropriate, and if anything, would underestimate the actual bone loss. For serum biomarkers, only TRAP5B, bone-specific Alkaline phosphatase (BSAP), and PINP are not altered with renal impairment (i.e., not partially cleared by the kidneys, leading to circulating fragments that render...

What is the maximum dose (mg/kg) you will push an IV TNFi to for a patient with Takayasu arteritis who is adherent and does not have evidence of anti-drug antibodies before switching to an alternate class of therapy?

1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Alabama Birmingham

For uveitis, I have used infliximab at 20 mg/kg/dose every 2 weeks to save vision.

How do you manage hypercalcemia in an osteoporosis patient on a PTH analogue?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Icahn School of Medicine at Mount Sinai

Teriparatide should not be prescribed to patients with pre-existing hypercalcemia or underlying hypercalcemic disorders such as primary hyperparathyroidism, as it may exacerbate hypercalcemia.[1][2][3] The Endocrine Society recommends that serum calcium be assessed prior to use and that teriparatide...

Are there instances in which you would combine belimumab and rituximab for management of difficult to control SLE?

4 Answers

Mednet Member
Mednet Member
Rheumatology · Ohio State University Wexner Medical Center

While I have not employed this combination in my own practice, I am aware of the proposed rationale that using belimumab and rituximab together could promote more sustained B-cell depression. This approach was tested in the BEAT-LUPUS trial, results published in Lancet Rheumatology in 2022. In this ...

Is Evenity appropriate for a patient with severe osteoporosis (T-score -3.1) unresponsive to bisphosphonates and persistent primary hyperparathyroidism despite two surgeries?

1
2 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

Before, I would institute therapy, I would like to know what the situation is with the primary hyperparathyroidism. Is this primary or FHH? Although a 24-hour urine calcium creatinine ratio is no longer helpful, I find that the serum phosphate and 1,25-dihydroxyvitamin D, along with 25-hydroxyvitami...

What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?

1
3 Answers

Mednet Member
Mednet Member
Rheumatology · Weill Cornell Medical College

I agree with Dr. @Dr. First Last's excellent suggestions (with just one exception!). I don't increase prednisone prophylactively for lupus pregnancy - I would only add or increase steroid if there is a flare. The risks of steroid in pregnancy impact both maternal and pregnancy outcomes, so we try to...